Supplementary Figure S3 from Interim Phase II Results Using Panitumumab-IRDye800CW During Transoral Robotic Surgery in Patients with Oropharyngeal Cancer
crossref(2024)
摘要
Supplementary Figure S3: Additional characterization of consecutive OPSCC presentations in a single patient.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要